Education
About Us
Working with TipRanks
Follow Us
CareDx (CDNA)
NASDAQ:CDNA
CDNA Analyst Ratings
Moderate Buy
3 Buy
5 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CDNA Stock 12 Month Forecast
Average Price Target
$19.50
▲(30.61% Upside)
| Highest Price Target$28.00 | Average Price Target$19.50 | Lowest Price Target$14.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
BTIG
$22
Buy
47.35%
Upside
Reiterated
09/23/25
TR | OpenAI - 4o
$14
Hold
-6.23%
Downside
Reiterated
09/12/25
AI Generated ArticleAI Generated Article
William Blair
―
Hold
―
Initiated
08/25/25
Hold Rating for CareDx Amid Revenue Uncertainties and Valuation DiscountWe believe the company’s synergistic and expanding portfolio of offerings, transplant cases growing in the midsingle digits annually, tailwinds from government initiatives like the IOTA (Increasing Organ Transplant Access) model, and CareDx’s leading share in the testing services are the ingredients for sticky, predictable, and profitable revenue growth. Better days ahead. CareDx has seen significant business pressures in recent history, including (ongoing) reimbursement headaches, patent litigation and securities investigations, and changes in the executive suite. Downside potential related to the draft LCD is likely priced in, but shares may be in a holding pattern until it is finalized. When this happens, shares could rebase and move much higher.Attractive financial profile.
Wells Fargo
$19→$14
Hold
-6.23%
Downside
Reiterated
08/08/25
H.C. Wainwright
―
Hold
―
Reiterated
08/08/25
Craig-Hallum
―
Buy
―
Reiterated
08/07/25
Goldman Sachs
$34→$26
Buy
74.15%
Upside
Reiterated
04/16/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
BTIG
$22
Buy
47.35%
Upside
Reiterated
09/23/25
TR | OpenAI - 4o
$14
Hold
-6.23%
Downside
Reiterated
09/12/25
AI Generated ArticleAI Generated Article
William Blair
―
Hold
―
Initiated
08/25/25
Hold Rating for CareDx Amid Revenue Uncertainties and Valuation DiscountWe believe the company’s synergistic and expanding portfolio of offerings, transplant cases growing in the midsingle digits annually, tailwinds from government initiatives like the IOTA (Increasing Organ Transplant Access) model, and CareDx’s leading share in the testing services are the ingredients for sticky, predictable, and profitable revenue growth. Better days ahead. CareDx has seen significant business pressures in recent history, including (ongoing) reimbursement headaches, patent litigation and securities investigations, and changes in the executive suite. Downside potential related to the draft LCD is likely priced in, but shares may be in a holding pattern until it is finalized. When this happens, shares could rebase and move much higher.Attractive financial profile.
Wells Fargo
$19→$14
Hold
-6.23%
Downside
Reiterated
08/08/25
H.C. Wainwright
―
Hold
―
Reiterated
08/08/25
Craig-Hallum
―
Buy
―
Reiterated
08/07/25
Goldman Sachs
$34→$26
Buy
74.15%
Upside
Reiterated
04/16/25
Best Analysts Covering CareDx
1 Month
xxx
Success Rate
6/20 ratings generated profit
Average Return
-8.48%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 30.00% of your transactions generating a profit, with an average return of -8.48% per trade.
3 Months
xxx
Success Rate
7/20 ratings generated profit
Average Return
-13.96%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 35.00% of your transactions generating a profit, with an average return of -13.96% per trade.
1 Year
Success Rate
4/11 ratings generated profit
Average Return
-8.66%
reiterated a buy rating 2 months ago
Copying William Bonello's trades and holding each position for 1 Year would result in 36.36% of your transactions generating a profit, with an average return of -8.66% per trade.
2 Years
xxx
Success Rate
3/20 ratings generated profit
Average Return
-43.42%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 15.00% of your transactions generating a profit, with an average return of -43.42% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CDNA Analyst Recommendation Trends
Rating
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Strong Buy
4
3
6
4
5
Buy
2
4
8
9
8
Hold
6
5
6
11
14
Sell
1
1
1
0
0
Strong Sell
0
0
0
0
0
total
13
13
21
24
27
Each month's total comprises the sum of three months' worth of ratings.
CDNA Financial Forecast
CDNA Stock Forecast FAQ
What is CDNA’s average 12-month price target, according to analysts?
Based on analyst ratings, CareDx’s 12-month average price target is 19.50.
What is CDNA’s upside potential, based on the analysts’ average price target?
CareDx has 30.61% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CDNA a Buy, Sell or Hold?
CareDx has a consensus rating of Moderate Buy which is based on 3 buy ratings, 5 hold ratings and 0 sell ratings.
What is CareDx’s price target?
The average price target for CareDx is 19.50. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $28.00 ,the lowest forecast is $14.00. The average price target represents 30.61% Increase from the current price of $14.93.
The highest analyst price target is $28.00 ,the lowest forecast is $14.00. The average price target represents 30.61% Increase from the current price of $14.93.
What do analysts say about CareDx?
CareDx’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of CDNA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.